TSH Biopharm Corp Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares TSH Biopharm Corp Limited with three other
companies in this sector in Taiwan:
Genovate Biotechnology Co., Limited
(2018
sales of 455.80 million Taiwanese Dollars [US$14.98 million]
of which 94%
was Medicine Manufacturing),
Tien Liang Biotech Co Ltd
(533.77 million Taiwanese Dollars [US$17.55 million]
of which 84%
was Tianliang Biology), and
Johnson Chemical Pharmaceutical Works Co Ltd
(411.91 million Taiwanese Dollars [US$13.54 million]
).
Sales Analysis.
TSH Biopharm Corp Limited reported sales of 515.65 million Taiwanese Dollars (US$16.95 million)
for the
year ending
December of 2018.
This
represents
an
increase of 6.0%
versus 2017, when the company's sales were 486.28 million Taiwanese Dollars.